Cell Culture Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Cell Culture Market is Segmented by Product and Consumables (Products(Biosafety Equipment, Centrifuges, Cryostorage Equipment, Culture Systems, Incubators, and Others) and Consumables (Media, Sera, and Reagents)), Application (Biopharmaceuticals, Drug Development, Gene Therapy, Tissue Culture and Engineering, Vaccine Production, and Others), and Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Cell Culture-1
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 11.1 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global cell culture market is expected to witness a CAGR of around 11.1% over the forecast period, 2021-2026.

In the context of COVID-19, government organizations in various countries, research institutes, and many biotechs and pharmaceutical firms are focusing on effective and rapid technologies for the fast diagnosis of COVID-19 and developing vaccines/new therapeutics to overcome the current situation. Cell culture may serve as a potential platform for the development of novel vaccines for the treatment of COVID-19. Researchers working on related coronaviruses SARS and MERS are focusing on cell culture-based treatment approaches for the COVID-19 treatment and conducting research in developing vaccines based on cell cultures.

In February 2020, Belgium Based CDMO Univercells received up to EUR 50 million financings from Gamma Biosciences, a new investment platform supported by a leading global investment firm, KKR, focused on next-generation bioprocessing technologies for the production of advanced biologic therapies, including gene- and cell-based therapies.

In general, the market for cell culture is driven by factors, such as rising demand for vaccines, artificial organs and biopharmaceuticals, and a growing focus on personalized medicine. For instance, in April 2019, Seqirus filed an Annual Strain Update with the US Food and Drug Administration (FDA) in the coming weeks, including the decision to manufacture its cell-based influenza vaccine (FLUCELVAX QUADRIVALENT) for the 2019/2020 season using a cell-based candidate vaccine virus (CVV) for all four influenza strains recommended by the World Health Organization (WHO). This decision makes the entire production process exclusively cell-based.

Additionally, there is a growing demand for personalized medicine across major developed economies. Technological advancements have helped researchers to come up with novel therapies that can help treat life-threatening diseases. For vaccines and personalized medicine, there is the mandatory use of cell culture. Hence, the market for cell culture is positively impacted due to the factors mentioned above.

Scope of the Report

As per the scope of the report, cell culture is the process of growing the cell under certain controlled conditions outside their natural environment. Once the cells of interest have been isolated from living tissue, they can subsequently be maintained under carefully controlled conditions. The cell culture market is segmented by product and consumables (products(biosafety equipment, centrifuges, cryostorage equipment, culture systems, incubators, others) and consumables (media, sera, and reagents)), application (biopharmaceuticals, drug development, gene therapy, tissue culture and engineering, vaccine production, and others), and geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Product and Consumables
Product
Biosafety Equipment
Centrifuges
Cryostorage Equipment
Culture Systems/Bioreactors
Incubators
Pipetting Instruments
Others
Consumables
Media
Sera
Reagents
By Application
Biopharmaceuticals
Drug Development
Gene Therapy
Tissue Culture and Engineering
Vaccine Production
Other Applications
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Drug Development Segment to Witness Rapid Growth

Cell culture is an integral part of medical research and drug discovery. The two-dimensional (2D) culture has been the preferred method for many decades due to the ease with which cell monolayers can be induced to proliferate on planar surfaces. The cell culture industry has witnessed the evolution, and currently, there has been an emergence of 3D cell culture in the market. Drug development is a time-consuming and costly procedure that is finished in multiple stages, from target identification to lead discovery and optimization, preclinical validation, and clinical trials culminating in approval for clinical use. Cell-based high throughput screening (HTS) is currently being carried out on cultured cells propagated in two dimensions (2D) on plastic surfaces optimized for tissue culture. With the emergence of 3D cell culture, the process of HTS has become easier and accurate.

Furthermore, with the COVID-19 outbreak situation, the drug development process is on peak, across the biotech industry. Several companies and research organizations are involved in developing coronavirus drugs/vaccines. For instance, Entos Pharmaceuticals, Roivant Sciences, Altimmune, Biopharma, etc., are involved in the drug development for treating the contagious coronavirus infection, which is expected to propel the segment growth.

Adding to the benefits of cell culture, growing drug discovery is being made, worldwide, augmenting the market's growth.

Medicines in Development for Cell and Gene Therapy 2018 and 2020

North America Dominates the Global Cell Culture Market Over the Forecast Period

North America is currently dominating the cell culture market and is expected to follow the same trend over the forecast period. This is majorly attributed to the growing demand for personalized medicine and the presence of key players in the market. Additionally, the United States government is supportive in terms of medical research as healthcare is one of the major priorities in the country. The Human Cancer Models Initiative was announced, which aimed to grow 1,000 new cell lines for scientists to study within three years. The initiative included the US National Cancer Institute (NCI) in Bethesda, Maryland, Cancer Research UK, the Wellcome Trust Sanger Institute UK, and Hubrecht Organoid Technology of Utrecht in the Netherlands.

Fetal bovine serum (FBS) is the most widely used growth supplement for cell culture because it cost-effectively supports the survival and growth of many cell lines. However, the FDA has put several requirements in place for the production process due to the risk of contamination. Furthermore, in 2019, the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) released their first official policy document on the joint regulation of cell-cultured meat. ​With the rising focus on cell-based research, it is believed that there may be more technological advancements in the field, and this is likely to impact the US market in a positive manner.

Additionally, with the COVID-19 pandemic still evolving with the new saints, researchers are working toward studying the mechanisms underlying COVID-19. For instance, on January 20, 2020, CDC received a specimen collected from the first reported patient in the United States and generated enough SARS-CoV-2 grown in cell culture to distribute to medical and scientific researchers. Thus, all these factors are projected to boost the market growth for cell culture in the United States.

Cell Culture Market - Growth Rate by Region - Image

Competitive Landscape

The cell culture market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. The presence of major market players, such as Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, etc., is increasing the overall competitive rivalry of the market. In October 2019, Thermo Fisher Scientific launched cell culture media, which is the first to remain stable when stored at room temperature​. The product advancements and improvements in cell culture platforms by the major players are increasing the competition.

Recent Developments

  • In March 2021: Thermo Fisher Scientific launched its new Gibco Human Plasma-like Medium (HPLM), the first type of cell culture medium that mimics the metabolic profile of human plasma and is designed to provide researchers with a realistic view of cell growth within the human body.
  • In January 2021: Captivate Bio launched its portfolio of cell culture tools to support the fight against COVID-19 and other emerging diseases and help address the gaps exposed by supply chain issues and delays in cell culture media manufacturing in the United States.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in the Demand for Vaccines, Biopharmaceuticals and Artificial Organs

      2. 4.2.2 Growing Focus on Personalized Medicine

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost Associated with Cell Based Research

      2. 4.3.2 Lack of Infrastructure for Cell-based Research in Emerging Economies

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Buyers/Consumers

      2. 4.4.2 Bargaining Power of Suppliers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product and Consumables

      1. 5.1.1 Product

        1. 5.1.1.1 Biosafety Equipment

        2. 5.1.1.2 Centrifuges

        3. 5.1.1.3 Cryostorage Equipment

        4. 5.1.1.4 Culture Systems/Bioreactors

        5. 5.1.1.5 Incubators

        6. 5.1.1.6 Pipetting Instruments

        7. 5.1.1.7 Others

      2. 5.1.2 Consumables

        1. 5.1.2.1 Media

        2. 5.1.2.2 Sera

        3. 5.1.2.3 Reagents

    2. 5.2 By Application

      1. 5.2.1 Biopharmaceuticals

      2. 5.2.2 Drug Development

      3. 5.2.3 Gene Therapy

      4. 5.2.4 Tissue Culture and Engineering

      5. 5.2.5 Vaccine Production

      6. 5.2.6 Other Applications

    3. 5.3 By Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Biospherix

      2. 6.1.2 CellGenix GmbH

      3. 6.1.3 Hi-Media Laboratories

      4. 6.1.4 Merck KGaA

      5. 6.1.5 Promocell GmbH

      6. 6.1.6 Sartorius AG

      7. 6.1.7 Thermo Fisher Scientific

      8. 6.1.8 Danaher Corporation

      9. 6.1.9 Sekisui XenoTech LLC

      10. 6.1.10 ANGUS Chemical Company

      11. 6.1.11 Lonza Group

      12. 6.1.12 Agilent Technologies Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Cell Culture Market market is studied from 2018 - 2026.

The Cell Culture Market is growing at a CAGR of 11.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, Merck KGaA, CellGenix GmbH are the major companies operating in Cell Culture Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!